Haploidentical Hematopoietic Stem Cell Transplantation Patients With Wiskott-Aldrich Syndrome

NCT00160355 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

4

Enrollment

OTHER

Sponsor class

Conditions

Wiskott-Aldrich Syndrome

Interventions

PROCEDURE: Hematopoietic stem cell transplantation
DEVICE: Miltenyi CliniMACS selection system
DRUG: Fludarabine, Melphalan, Thiotepa

Sponsor

St. Jude Children's Research Hospital